Board of Directors

Agneta Edberg Chairman Alumni Stockholm School of Economics, Biomedical Analyst. Born: 1956. Experience: Currently Nordic CEO of Mylan. Before: LinkMed's COO and VP Senior Venture Manager, Vice President, Bactiguard AB. CEO for LFF Service AB, The Swedish Pharmaceutical Insurance Association, 2005–2006. Previous leading positions at Pfizer and Pharmacia, CEO for NM Pharma AB, Cederroth International, Farmos Group AB, and Cilag AB. Chairperson of the VinnExcellence project BioMatCell. Bengt Furberg Board Member M.D., Ph.D., Associate Professor Clinical Physiology Born: 1941. Experience: Bengt Furberg has extensive experience from clinical trials and has written several books and scientific articles within the field. He spent 10 years as Medical Director of British GlaxoWellcome in Sweden and was also part of the company's management team in addition to being member of the corporate group's Medical Board and Safety Board. Since 1994, he has also been member of the Swedish Academy for Pharmaceutical Sciences. Bengt Furberg currently works as VP of Medical Affairs at Artimplant. Per-Olof Gunnesson Board Member MBA Born: 1945. Experience: Currently VP of Business Development and Finance at InDex Pharmaceuticals. Before: Over 40 years of experience from the pharmaceutical industry. Mr Gunnesson has held several management positions at the Astra Group where he among other things acted as Vice President of Finance and Licensing. Alex Karlsson-Parra Board Member M.D., Ph.D. Clinical Immunology Born: 1950. Experience: Over 20 years of experience from work within the field of transplantation immunology and former Chairman of the Swedish Expert Committee in Clinical Immunology. Bengt Andersson Board Member M.D., Ph.D. Clinical Immunology Born: 1952. Experience: Over 20 years of experience from work within the field of infection immunology. Martin Lindström Board Member M.Sc. Civil Engineering, B.Sc. Business and Administration Born: 1980. Experience: Managing a real estate company.